Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Non-Animal Softgel Capsule Market: By Material Type, By Application, and Region Forecast 2020-2031
Non-Animal Softgel Capsule Market size was valued at US$ 1.3 billion in 2024 and is expected to reach US$ 2.0 billion by 2031, growing at a significant CAGR of 6.2% from 2025-2031. The global market for non-animal soft gel capsules is anticipated to rise due to the rising availability of vegetarian soft gel capsules and the rising demand for plant-based softgel capsules from pharmaceutical and nutraceutical companies. Today's healthcare companies operate in a dynamic environment undergoing seismic changes due to the advent of cutting-edge medical procedures and increasing internet usage. Astute patients have become more cautious due to this and unmatched online access to incredible volumes of information. There is a growing demand for intelligent, reasonably priced, and customized healthcare services. The overall consumer trend in the health sector indicates an increased demand for natural products and cutting-edge dosage techniques.
The absence of gelatin derived from animal waste gives vegetarian soft gels a significant benefit. These soft starch gels can be consumed without worrying about contracting an animal disease; thus, vegetarians can use them. The vegetarian soft gels are less brittle even in low humidity since they are chemically stable and have a low moisture content. Companies that produce halal soft gel capsules have received halal certification from the Islamic Food and Nutrition Council of America (IFANCA). It is anticipated that this will generate a substantial market for these pills in nations with most Muslims. Furthermore, the market for plant-based softgel capsules is also seeing a surge in demand for them because of their advantages and uses and the high availability of natural raw ingredients for their formulation. Additionally, a sizable population of health-conscious consumers and an increase in pharmaceutical industry innovations for producing soft gel capsules are two potential catalysts for the market.
Study Period
2025-2031Base Year
2024CAGR
6.2%Largest Market
North-AmericaFastest Growing Market
North-America
Non-animal soft gel capsules are made from organic plant-based sources, are free of GMOs and animal derivatives, and don't include gluten or refined sugar. They comprise cellulose, pullulan, and starch (Hydroxypropyl Methylcellulose). Consumers looking for an animal-free alternative to gelatin capsules will find vegetarian capsules the perfect solution. The demand for non-animal soft gel capsules is rising as the number of vegans rises. Additionally, the market is being driven forward by the availability of natural raw materials for the production of vegetarian soft gel capsules and the increase in demand for these products due to their benefits and uses. Due to their specialized raw materials and manufacturing processes, vegetarian soft gel capsules have a high manufacturing cost, which is expected to impede market growth over the forecast period.
Report Benchmarks |
Details |
Report Study Period |
2025-2031 |
Market Size in 2024 |
US$ 1.3 billion |
Market Size in 2031 |
US$ 2.0 billion |
Market CAGR |
6.2% |
By Material Type |
|
By Application |
|
By Region |
|
Download Free Sample Report
Non-Animal Softgel Capsule Market size was valued at US$ 1.3 billion in 2024 and is expected to reach US$ 2.0 billion by 2031, growing at a CAGR of 6.2%.
Amway, Capsugel, Catalent, Eurocaps, Procaps Laboratorios, Patheon, SIRIO
North America is the fastest-growing region for non-animal softgel capsule market
1.Executive Summary |
2.Global Non-Animal Softgel Capsule Market Introduction |
2.1.Global Non-Animal Softgel Capsule Market - Taxonomy |
2.2.Global Non-Animal Softgel Capsule Market - Definitions |
2.2.1. By Material Type |
2.2.2. By Application |
2.2.3. By Region |
3.Global Non-Animal Softgel Capsule Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Non-Animal Softgel Capsule Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Non-Animal Softgel Capsule Market By Material Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
5.1. Starch |
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Carrageenan-Starch Blends |
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others |
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Non-Animal Softgel Capsule Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
6.1. Pharmaceuticals |
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Healthcare Supplements |
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Non-Animal Softgel Capsule Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Non-Animal Softgel Capsule Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
8.1. Material Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Starch |
8.1.2.Carrageenan-Starch Blends |
8.1.3.Others |
8.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Pharmaceuticals |
8.2.2.Healthcare Supplements |
8.2.3.Others |
8.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Non-Animal Softgel Capsule Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
9.1. Material Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Starch |
9.1.2.Carrageenan-Starch Blends |
9.1.3.Others |
9.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Pharmaceuticals |
9.2.2.Healthcare Supplements |
9.2.3.Others |
9.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
10.Asia Pacific (APAC) Non-Animal Softgel Capsule Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
10.1. Material Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Starch |
10.1.2.Carrageenan-Starch Blends |
10.1.3.Others |
10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Pharmaceuticals |
10.2.2.Healthcare Supplements |
10.2.3.Others |
10.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Non-Animal Softgel Capsule Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
11.1. Material Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Starch |
11.1.2.Carrageenan-Starch Blends |
11.1.3.Others |
11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Pharmaceuticals |
11.2.2.Healthcare Supplements |
11.2.3.Others |
11.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Non-Animal Softgel Capsule Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
12.1. Material Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Starch |
12.1.2.Carrageenan-Starch Blends |
12.1.3.Others |
12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Pharmaceuticals |
12.2.2.Healthcare Supplements |
12.2.3.Others |
12.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Capsugel |
13.2.2.Amway |
13.2.3.Patheon |
13.2.4.Catalent |
13.2.5.Procaps Laboratorios |
13.2.6.Eurocaps |
13.2.7.Best Formulations |
13.2.8.Aenova |
13.2.9.Captek |
13.2.10.SIRIO |
13.2.11.Capsugel |
13.2.12.Robinson Pharma |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players